Dr. Thomas Ulas
Life & Medical Sciences Institute (LIMES)
t.ulas@uni-bonn.de View member: Dr. Thomas Ulas
Glia
The tight regulation of microglia activity is key for precise responses to potential threats, while uncontrolled and exacerbated microglial activity is neurotoxic. Microglial toll-like receptors (TLRs) are indispensable for sensing different types of assaults and triggering an innate immune response. Cannabinoid receptor 2 (CB2) signaling is a key pathway to control microglial homeostasis and activation, and its activation is connected to changes in microglial activity. We aimed to investigate how CB2 signaling impacts TLR-mediated microglial activation. Here, we demonstrate that deletion of CB2 causes a dampened transcriptional response to prototypic TLR ligands in microglia. Loss of CB2 results in distinct microglial gene expression profiles, morphology, and activation. We show that the CB2-mediated attenuation of TLR-induced microglial activation is mainly p38 MAPK-dependent. Taken together, we demonstrate that CB2 expression and signaling are necessary to fine-tune TLR-induced activation programs in microglia.
© 2021 The Authors. GLIA published by Wiley Periodicals LLC.
PMID: 34499767
Life & Medical Sciences Institute (LIMES)
t.ulas@uni-bonn.de View member: Dr. Thomas UlasDeutsches Zentrum für Neurodegenerative Erkrankungen e. V. (DZNE)
marc.beyer@dzne.de View member: PD Dr. Marc BeyerInstitute of Molecular Psychiatry (IMP)
neuro@uni-bonn.de View member: Prof. Dr. Andreas Zimmer